Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Cigna Group (NYSE: CI) closed at $276.01 in the last session, down -0.18% from day before closing price of $276.51. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 0.94 million shares were traded. CI stock price reached its highest trading level at $277.8899 during the session, while it also had its lowest trading level at $275.31.
Ratios:
We take a closer look at CI’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.74.
Upgrades & Downgrades
In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $370.
On February 06, 2025, Bernstein Downgraded its rating to Mkt Perform which previously was Outperform but kept the price unchanged to $323.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.Piper Sandler initiated its Overweight rating on June 26, 2024, with a $400 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 03 ’25 when Cordani David bought 4,134 shares for $241.88 per share. The transaction valued at 999,916 led to the insider holds 157,935 shares of the business.
Evanko Brian C sold 5,368 shares of CI for $1,610,400 on Oct 03 ’25. The insider now owns 51,182 shares after completing the transaction at $300.00 per share. On Oct 03 ’25, another insider, Evanko Brian C, who serves as the Officer of the company, bought 5,368 shares for $300.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 73729400832 and an Enterprise Value of 101070397440. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.18, and their Forward P/E ratio for the next fiscal year is 9.08. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.27 while its Price-to-Book (P/B) ratio in mrq is 1.76. Its current Enterprise Value per Revenue stands at 0.377 whereas that against EBITDA is 8.676.
Stock Price History:
The Beta on a monthly basis for CI is 0.27, which has changed by 0.0013399124 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $350.00, while it has fallen to a 52-week low of $239.51. The 50-Day Moving Average of the stock is 0.12%, while the 200-Day Moving Average is calculated to be -8.24%.
Shares Statistics:
According to the various share statistics, CI traded on average about 1.99M shares per day over the past 3-months and 1639950 shares per day over the past 10 days. A total of 266.60M shares are outstanding, with a floating share count of 262.80M. Insiders hold about 1.62% of the company’s shares, while institutions hold 90.36% stake in the company. Shares short for CI as of 1765756800 were 4484017 with a Short Ratio of 2.26, compared to 1763078400 on 3934852. Therefore, it implies a Short% of Shares Outstanding of 4484017 and a Short% of Float of 2.22.
Dividends & Splits
The forward annual dividend rate for CI is 6.04, which was 5.93 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.021445878. The stock’s 5-year Average Dividend Yield is 1.49. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-12-04 with an ex-dividend date of 2025-12-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
. The current assessment of Cigna Group (CI) involves the perspectives of 22.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $7.24, with high estimates of $7.86 and low estimates of $6.51.
Analysts are recommending an EPS of between $29.78 and $29.53 for the fiscal current year, implying an average EPS of $29.64. EPS for the following year is $30.47, with 24.0 analysts recommending between $32.82 and $29.96.
Revenue Estimates
According to 12 analysts,. The current quarter’s revenue is expected to be $68.95B. It ranges from a high estimate of $74.72B to a low estimate of $65.25B. As of. The current estimate, Cigna Group’s year-ago sales were $65.68BFor the next quarter, 12 analysts are estimating revenue of $67.2B. There is a high estimate of $71.2B for the next quarter, whereas the lowest estimate is $64.19B.
A total of 14 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $277.15B, while the lowest revenue estimate was $253.3B, resulting in an average revenue estimate of $269.31B. In the same quarter a year ago, actual revenue was $247.1BBased on 13 analysts’ estimates, the company’s revenue will be $281.25B in the next fiscal year. The high estimate is $306.37B and the low estimate is $263.33B.
